MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejrad.2026.113214

Медицинская библиотека · European journal of radiology · 2026

A multimodal cross-temporal fusion system for complementary evaluation of neoadjuvant chemotherapy in breast cancer.

Sun Xinyi, Wang Dezhen, Zhou Qidi, Liu Wenfeng, Gao Xueqiang, Shen Xiangyu, Yang Xiaonan, Ma Teng, Ma Tianyi, Liu Changgen, He Yinxin, Li Yifan, Wang Weiwei, Song Lijun, Mao Yan, Wang Haibo

СтатьяПеревод в очереди

Аннотация

PURPOSE: Neoadjuvant chemotherapy (NAC) has been established as a standard treatment for breast cancer. We aimed to develop a deep-learning multimodal system using longitudinal cross-temporal dynamic contrast-enhanced MRI (DCE-MRI) and clinical data to provide complementary evaluation of NAC.

METHODS

Here, we developed a multimodal automatic NAC assistance system (MANAS), which leverages a dual-pathway attention-based multi-scale feature fusion framework and a multicenter dataset. This dataset comprises pre- and post-NAC DCE-MRI and associated clinical information of 1,515 patients with locally advanced breast cancer. The performance of MANAS was evaluated using various metrics. Confidence-based decision criteria were employed to defer low-confidence cases to clinicians.

RESULTS

MANAS consisted of three modules from breast cancer diagnosis to follow-up treatment, designed for predicting molecular subtype, NAC response, and residual tumor burden, respectively. MANAS achieved area under the curves (AUCs) of 0.8066 (95 % CI: 0.7552-0.8599), 0.7748 (95 % CI: 0.7210-0.8275) and 0.7661 (95 % CI: 0.6980-0.8252) on the internal, pooled external and I-SPY2 test sets for molecular subtype prediction; AUCs of 0.8400 (95 % CI: 0.7903-0.8896) and 0.8299 (95 % CI: 0.7886-0.8687) on the internal and pooled external test sets for NAC response prediction; and AUCs of 0.8885 (95 % CI: 0.7891-0.9657), 0.8628 (95 % CI: 0.8047-0.9132) and 0.8695 (95 % CI: 0.7856-0.9432) on the internal, pooled external and I-SPY2 test sets for residual tumor burden prediction. Confidence-based decision criteria could enhance their predictive performance.

CONCLUSION

Our MANAS serves as a valuable complementary tool, providing longitudinal supportive evidence throughout the NAC process, from initial diagnosis to surgical intervention.

Для цитирования: Sun Xinyi, Wang Dezhen, Zhou Qidi, Liu Wenfeng, Gao Xueqiang, Shen Xiangyu, Yang Xiaonan, Ma Teng, Ma Tianyi, Liu Changgen, He Yinxin, Li Yifan, Wang Weiwei, Song Lijun, Mao Yan, Wang Haibo. A multimodal cross-temporal fusion system for complementary evaluation of neoadjuvant chemotherapy in breast cancer.. European journal of radiology. 2026. DOI: 10.1016/j.ejrad.2026.113214.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.